6 September 2019

EATRIS, the European infrastructure for translational medicine, obtained funding for a new flagship project for sustainability and personalised medicine: EATRIS-Plus. Alain van Gool (LabGK), Peter-Bram ‘t Hoen (CMBI) and Ariaan Siezen (IM) are co-PI’s and receive approximately 550 k€ from this 5M€ Horizon2020 infrastructure development grant.

The project aims to build further capabilities and deliver innovative scientific tools to support the long-term sustainability of EATRIS. A key output of the project will be the piloting and delivery of a multi-omic toolbox, that will include SOPs, guidelines for best practices, reference materials, quality parameters, analysis tools, criteria for establishing reference values, and will provide access to a repository of multi-omic data. Objectives that are in line with the ambitions of the Netherlands X-omics Initiative, coordinated by Van Gool.

EATRIS covers over 90 institutes across Europe, among which Radboudumc. It has shown strong proof of concept of the value and utility of its translational medicine services portfolio, with users including academia, SMEs, large pharma, biotech and research funding organisations. The overarching aim of EATRIS-Plus is to further support the long-term sustainability of EATRIS by delivering innovative scientific tools to the personalised medicine research community. EATRIS-Plus will help pooling and utilising the translational academic capacities of the infrastructure in omics technologies to enable researchers to better address the scientific and societal challenges of personalised medicine.

More information: link. 

Related news items


Miniaturized microfluidic platform for automated epigenetic profiling

6 May 2021

Together with Fluidigm, a US-based company focusing on microfluidics, the team of Hendrik Marks publishes in Genome Research the development of a powerful plug and play ChIP-seq platform for minute amount of cells, such as embryonic specimens or small biopsies.

read more

Annual Paper Awards of Research Theme Tumors of the Digestive Tract

4 May 2021

The annual Paper Awards session of the Research Theme Tumors of the Digestive Tract took place at the 22nd of April. The selected candidates prepared wonderful informative movies, that were judged by the public of the RRR and by our patient representatives.

read more

Radboud university medical center appoints thirteen female professors

29 April 2021

Their fields of expertise cover the entire (bio-)medical field, ranging from fundamental and translational to clinical research, education and patient care.

read more

Embryonic development and magnesium homeostasis is regulated by Cyclin M2

29 April 2021

Gijs Franken and colleagues, theme Renal disorders, published in Scientific Reports that Cyclin M2 (CNNM2) is vital for embryonic development and magnesium homeostasis.

read more

Medication for the body's malfunctioning energy system in the works

28 April 2021

Radboudumc’s spin-off company Khondrion is developing the promising drug sonlicromanol for treating energy metabolism diseases. Founder of the company Jan Smeitink, theme metabolic disorders, explains.

read more

E-learning avoids gastroscopy in patients with stomach complaints

28 April 2021

Many patients with stomach complaints who are referred for a gastroscopy actually do not need that unpleasant examination. Thanks to an e-learning module, they become more aware of their complaints and many of them refrain from such an examination.

read more